{"transactions":[{"id":4613391,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":20815,"kind":"person","name":"Luderer Albert","position":1,"cik":"0001746822","reported_name":"Luderer Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Executive"}}],"security":"Common Stock","published_at":"2026-09-09T20:30:06.000Z","date":"2026-09-04","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":1.2112,"value":4844.8,"ownership":{"direct":false,"nature":"Traditional IRA"},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001746822-26-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746822/000174682226000005/ownership.xml","form_type":"4"}},{"id":678639,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":20815,"kind":"person","name":"Luderer Albert","position":1,"cik":"0001746822","reported_name":"Luderer Albert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Executive"}}],"security":"Common Stock","published_at":"2026-08-21T20:30:16.000Z","date":"2026-08-21","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":1.215,"value":4860.0,"ownership":{"direct":false,"nature":"Traditional IRA"},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001746822-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174682226000003/ownership.xml","form_type":"4"}},{"id":695506,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26208,"kind":"person","name":"Adamchak Mark","position":1,"cik":"0002036536","reported_name":"Adamchak Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-05T21:28:01.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed."}],"balance_after":5000,"derivative":{"exercise_price":1.12,"expiration_date":"2036-08-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0002036536-26-000010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000203653626000010/ownership.xml","form_type":"4"}},{"id":695504,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-05T21:27:39.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed."}],"balance_after":15000,"derivative":{"exercise_price":1.12,"expiration_date":"2036-08-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001967837-26-000010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000196783726000010/ownership.xml","form_type":"4"}},{"id":695503,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-05T21:27:13.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed."}],"balance_after":15000,"derivative":{"exercise_price":1.12,"expiration_date":"2036-08-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001745566-26-000010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556626000010/ownership.xml","form_type":"4"}},{"id":695502,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26207,"kind":"person","name":"Hastie Alex Reid","position":1,"cik":"0002147380","reported_name":"Hastie Alex Reid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-05T21:26:42.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest and become exercisable on August 2, 2027, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from August 2, 2027, subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each such applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed."}],"balance_after":54000,"derivative":{"exercise_price":1.12,"expiration_date":"2036-08-02","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0002147380-26-000006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000214738026000006/ownership.xml","form_type":"4"}},{"id":751449,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-06-04T00:52:07.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24,"price":1.3,"value":31.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":239,"source":{"system":"sec-edgar","filing":"0001967837-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000196783726000006/ownership.xml","form_type":"4"}},{"id":751448,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-06-04T00:51:22.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":27,"price":1.3,"value":35.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":868,"source":{"system":"sec-edgar","filing":"0001745566-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556626000006/ownership.xml","form_type":"4"}},{"id":751450,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-04T00:50:33.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24,"price":1.3,"value":31.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":620,"source":{"system":"sec-edgar","filing":"0001821605-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000182160526000006/ownership.xml","form_type":"4"}},{"id":751447,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26208,"kind":"person","name":"Adamchak Mark","position":1,"cik":"0002036536","reported_name":"Adamchak Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-06-04T00:50:00.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":7,"price":1.3,"value":9.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":253,"source":{"system":"sec-edgar","filing":"0002036536-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000203653626000006/ownership.xml","form_type":"4"}},{"id":778878,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47299,"kind":"person","name":"Rajkovic Aleksandar","position":1,"cik":"0001909592","reported_name":"Rajkovic Aleksandar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-14T22:16:45.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":9149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":9149,"derivative":{"exercise_price":1.19,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":9149},"source":{"system":"sec-edgar","filing":"0001909592-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000190959226000002/ownership.xml","form_type":"4"}},{"id":779351,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47359,"kind":"person","name":"Linney Yvonne","position":1,"cik":"0001810930","reported_name":"Linney Yvonne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-14T22:16:16.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":9149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":9149,"derivative":{"exercise_price":1.19,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":9149},"source":{"system":"sec-edgar","filing":"0001810930-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810930/000181093026000002/ownership.xml","form_type":"4"}},{"id":778877,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-14T22:15:40.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":9149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":9149,"derivative":{"exercise_price":1.19,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":9149},"source":{"system":"sec-edgar","filing":"0001612627-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000161262726000002/ownership.xml","form_type":"4"}},{"id":778875,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":44686,"kind":"person","name":"TWOMEY CHRISTOPHER J","position":1,"cik":"0001238935","reported_name":"TWOMEY CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-14T22:15:10.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":9149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":9149,"derivative":{"exercise_price":1.19,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":9149},"source":{"system":"sec-edgar","filing":"0001238935-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000123893526000003/ownership.xml","form_type":"4"}},{"id":778874,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-14T22:14:47.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":9149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":9149,"derivative":{"exercise_price":1.19,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":9149},"source":{"system":"sec-edgar","filing":"0001189124-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000118912426000002/ownership.xml","form_type":"4"}},{"id":896549,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-18T21:31:45.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":18,"price":1.1,"value":19.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":644,"source":{"system":"sec-edgar","filing":"0001821605-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000182160526000004/ownership.xml","form_type":"4"}},{"id":896548,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26208,"kind":"person","name":"Adamchak Mark","position":1,"cik":"0002036536","reported_name":"Adamchak Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-18T21:29:36.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3,"price":1.1,"value":3.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 3 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":260,"source":{"system":"sec-edgar","filing":"0002036536-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000203653626000004/ownership.xml","form_type":"4"}},{"id":896547,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2026-02-18T21:28:24.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":6,"price":1.1,"value":6.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 6 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":263,"source":{"system":"sec-edgar","filing":"0001967837-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000196783726000004/ownership.xml","form_type":"4"}},{"id":896546,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-02-18T21:26:55.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":20,"price":1.1,"value":22.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":895,"source":{"system":"sec-edgar","filing":"0001745566-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556626000004/ownership.xml","form_type":"4"}},{"id":896545,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2026-02-18T21:25:37.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":51,"price":1.1,"value":56.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":1657,"source":{"system":"sec-edgar","filing":"0001579988-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000157998826000004/ownership.xml","form_type":"4"}},{"id":919270,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26208,"kind":"person","name":"Adamchak Mark","position":1,"cik":"0002036536","reported_name":"Adamchak Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:19:48.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":10890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option vest on the one-year anniversary of the grant date."}],"balance_after":10890,"derivative":{"exercise_price":1.27,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":10890},"source":{"system":"sec-edgar","filing":"0002036536-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000203653626000002/ownership.xml","form_type":"4"}},{"id":919269,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:18:34.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":27737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":27737,"derivative":{"exercise_price":1.27,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":27737},"source":{"system":"sec-edgar","filing":"0001821605-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000182160526000002/ownership.xml","form_type":"4"}},{"id":919268,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:17:32.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":27737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":27737,"derivative":{"exercise_price":1.27,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":27737},"source":{"system":"sec-edgar","filing":"0001745566-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556626000002/ownership.xml","form_type":"4"}},{"id":919267,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:16:00.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":26117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":26117,"derivative":{"exercise_price":1.27,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":26117},"source":{"system":"sec-edgar","filing":"0001967837-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000196783726000002/ownership.xml","form_type":"4"}},{"id":919266,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:14:16.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":69484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":69484,"derivative":{"exercise_price":1.27,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":69484},"source":{"system":"sec-edgar","filing":"0001579988-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000157998826000002/ownership.xml","form_type":"4"}},{"id":1041367,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-12T21:02:22.000Z","date":"2025-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":59,"price":4.06,"value":239.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":915,"source":{"system":"sec-edgar","filing":"0001745566-25-000007","document":"wk-form4a_1757710939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556625000007/wk-form4a_1757710939.xml","form_type":"4/A","original_submission_date":"2025-09-12"}},{"id":1041368,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-12T20:49:30.000Z","date":"2025-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":59,"price":4.06,"value":239.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":915,"source":{"system":"sec-edgar","filing":"0001745566-25-000005","document":"wk-form4_1757710167.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000174556625000005/wk-form4_1757710167.xml","form_type":"4"}},{"id":1041364,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-12T20:49:08.000Z","date":"2025-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":51,"price":4.06,"value":207.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 51 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 51 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":662,"source":{"system":"sec-edgar","filing":"0001821605-25-000006","document":"wk-form4_1757710145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000182160525000006/wk-form4_1757710145.xml","form_type":"4"}},{"id":1113191,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":44686,"kind":"person","name":"TWOMEY CHRISTOPHER J","position":1,"cik":"0001238935","reported_name":"TWOMEY CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:51:11.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option\nholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000070","document":"wk-form4_1749761462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000070/wk-form4_1749761462.xml","form_type":"4"}},{"id":1113192,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:50:58.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option\nholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000069","document":"wk-form4_1749761452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000069/wk-form4_1749761452.xml","form_type":"4"}},{"id":1113593,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47359,"kind":"person","name":"Linney Yvonne","position":1,"cik":"0001810930","reported_name":"Linney Yvonne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:50:47.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option\nholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000068","document":"wk-form4_1749761441.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810930/000141169025000068/wk-form4_1749761441.xml","form_type":"4"}},{"id":1113190,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":20815,"kind":"person","name":"Luderer Albert","position":1,"cik":"0001746822","reported_name":"Luderer Albert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:50:37.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option\nholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000067","document":"wk-form4_1749761430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000067/wk-form4_1749761430.xml","form_type":"4"}},{"id":1113189,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:50:28.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000066","document":"wk-form4_1749761417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000066/wk-form4_1749761417.xml","form_type":"4"}},{"id":1113186,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47299,"kind":"person","name":"Rajkovic Aleksandar","position":1,"cik":"0001909592","reported_name":"Rajkovic Aleksandar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:50:03.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option\nholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000064","document":"wk-form4_1749761396.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000064/wk-form4_1749761396.xml","form_type":"4"}},{"id":1113592,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T16:50:13.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option\nholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":2775,"derivative":{"exercise_price":3.67,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":2775},"source":{"system":"sec-edgar","filing":"0001411690-25-000065","document":"wk-form4_1749761408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000141169025000065/wk-form4_1749761408.xml","form_type":"4"}},{"id":1124673,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-06-03T22:59:01.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":27,"price":3.69,"value":99.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":974,"source":{"system":"sec-edgar","filing":"0001411690-25-000056","document":"wk-form4_1748991535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000056/wk-form4_1748991535.xml","form_type":"4"}},{"id":1124672,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26208,"kind":"person","name":"Adamchak Mark","position":1,"cik":"0002036536","reported_name":"Adamchak Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-06-03T22:58:51.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":7,"price":3.69,"value":25.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":263,"source":{"system":"sec-edgar","filing":"0001411690-25-000055","document":"wk-form4_1748991525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000055/wk-form4_1748991525.xml","form_type":"4"}},{"id":1124670,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-06-03T22:58:41.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24,"price":3.69,"value":88.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":713,"source":{"system":"sec-edgar","filing":"0001411690-25-000054","document":"wk-form4_1748991515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000054/wk-form4_1748991515.xml","form_type":"4"}},{"id":1124671,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-06-03T22:58:31.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":75,"price":3.69,"value":276.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 75 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 75 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":1708,"source":{"system":"sec-edgar","filing":"0001411690-25-000053","document":"wk-form4_1748991505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000053/wk-form4_1748991505.xml","form_type":"4"}},{"id":1124669,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-06-03T22:58:21.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":25,"price":3.69,"value":92.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 25 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 25 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":269,"source":{"system":"sec-edgar","filing":"0001411690-25-000052","document":"wk-form4_1748991495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000052/wk-form4_1748991495.xml","form_type":"4"}},{"id":1199464,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T22:45:55.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":6559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":6559,"derivative":{"exercise_price":3.47,"expiration_date":"0035-03-13","underlying":"Common Stock","underlying_shares":6559},"source":{"system":"sec-edgar","filing":"0001411690-25-000030","document":"wk-form4_1742337949.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000030/wk-form4_1742337949.xml","form_type":"4"}},{"id":1199465,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26208,"kind":"person","name":"Adamchak Mark","position":1,"cik":"0002036536","reported_name":"Adamchak Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T22:45:45.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":3029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option vest on the one-year anniversary of the grant date."}],"balance_after":3029,"derivative":{"exercise_price":3.47,"expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":3029},"source":{"system":"sec-edgar","filing":"0001411690-25-000029","document":"wk-form4_1742337939.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000029/wk-form4_1742337939.xml","form_type":"4"}},{"id":1199463,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T22:45:35.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":17449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":17449,"derivative":{"exercise_price":3.47,"expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":17449},"source":{"system":"sec-edgar","filing":"0001411690-25-000028","document":"wk-form4_1742337929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000028/wk-form4_1742337929.xml","form_type":"4"}},{"id":1199462,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-18T22:45:35.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":198,"price":3.47,"value":687.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award."}],"balance_after":1783,"source":{"system":"sec-edgar","filing":"0001411690-25-000028","document":"wk-form4_1742337929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000028/wk-form4_1742337929.xml","form_type":"4"}},{"id":1199461,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T22:45:26.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":6966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":6966,"derivative":{"exercise_price":3.47,"expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":6966},"source":{"system":"sec-edgar","filing":"0001411690-25-000027","document":"wk-form4_1742337920.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000027/wk-form4_1742337920.xml","form_type":"4"}},{"id":1199460,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T22:45:16.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":6966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date."}],"balance_after":6966,"derivative":{"exercise_price":3.47,"expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":6966},"source":{"system":"sec-edgar","filing":"0001411690-25-000026","document":"wk-form4_1742337909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000026/wk-form4_1742337909.xml","form_type":"4"}},{"id":1259591,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-02-19T23:57:21.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":20,"price":5.73,"value":114.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 60,262 less shares of common stock."}],"balance_after":1001,"source":{"system":"sec-edgar","filing":"0001411690-25-000019","document":"wk-form4_1740009430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000019/wk-form4_1740009430.xml","form_type":"4"}},{"id":1259587,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-02-19T23:57:06.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":6,"price":5.73,"value":34.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 6 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 6 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 17,725 less shares of common stock."}],"balance_after":294,"source":{"system":"sec-edgar","filing":"0001411690-25-000018","document":"wk-form4_1740009420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000018/wk-form4_1740009420.xml","form_type":"4"}},{"id":1259586,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-19T23:56:56.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":51,"price":5.73,"value":292.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 120,428 less shares of common stock (119,934 less shares held directly and 494 less shares held indirectly)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024 (As adjusted for the January 2025 Reverse Stock Split)."}],"balance_after":1981,"source":{"system":"sec-edgar","filing":"0001411690-25-000017","document":"wk-form4_1740009410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000017/wk-form4_1740009410.xml","form_type":"4"}},{"id":1259588,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-19T23:56:46.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":18,"price":5.73,"value":103.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 44,568 less shares of common stock."}],"balance_after":737,"source":{"system":"sec-edgar","filing":"0001411690-25-000016","document":"wk-form4_1740009400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000016/wk-form4_1740009400.xml","form_type":"4"}},{"id":1259585,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26208,"kind":"person","name":"Adamchak Mark","position":1,"cik":"0002036536","reported_name":"Adamchak Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-02-19T23:56:36.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4,"price":5.73,"value":22.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 4 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 4 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 16,197 less shares of common stock."}],"balance_after":270,"source":{"system":"sec-edgar","filing":"0001411690-25-000015","document":"wk-form4_1740009387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000015/wk-form4_1740009387.xml","form_type":"4"}},{"id":1394125,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26208,"kind":"person","name":"Adamchak Mark","position":1,"cik":"0002036536","reported_name":"Adamchak Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-02T23:13:54.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option vest on the one-year anniversary of the grant date."}],"balance_after":17500,"derivative":{"exercise_price":0.42,"expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001411690-24-000057","document":"wk-form4_1727910827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000057/wk-form4_1727910827.xml","form_type":"4"}},{"id":1407580,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-09-13T20:15:18.000Z","date":"2024-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3568,"price":0.48,"value":1712.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 3,568 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 3,568 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 153 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024."}],"balance_after":61283,"source":{"system":"sec-edgar","filing":"0001411690-24-000053","document":"wk-form4_1726258505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000053/wk-form4_1726258505.xml","form_type":"4"}},{"id":1407579,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-09-13T20:11:09.000Z","date":"2024-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3075,"price":0.48,"value":1476.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 3,075 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer an aggregate of 3,075 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 153 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024."}],"balance_after":45323,"source":{"system":"sec-edgar","filing":"0001411690-24-000052","document":"wk-form4_1726258263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000052/wk-form4_1726258263.xml","form_type":"4"}},{"id":1473031,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47299,"kind":"person","name":"Rajkovic Aleksandar","position":1,"cik":"0001909592","reported_name":"Rajkovic Aleksandar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:23:26.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000037","document":"wk-form4_1718914999.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000037/wk-form4_1718914999.xml","form_type":"4"}},{"id":1473030,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":20815,"kind":"person","name":"Luderer Albert","position":1,"cik":"0001746822","reported_name":"Luderer Albert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:23:15.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000036","document":"wk-form4_1718914987.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000036/wk-form4_1718914987.xml","form_type":"4"}},{"id":1473029,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:23:04.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000035","document":"wk-form4_1718914977.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000035/wk-form4_1718914977.xml","form_type":"4"}},{"id":1473028,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:22:53.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000034","document":"wk-form4_1718914965.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000034/wk-form4_1718914965.xml","form_type":"4"}},{"id":1473027,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":44686,"kind":"person","name":"TWOMEY CHRISTOPHER J","position":1,"cik":"0001238935","reported_name":"TWOMEY CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:22:20.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000031","document":"wk-form4_1718914933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169024000031/wk-form4_1718914933.xml","form_type":"4"}},{"id":1473313,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47359,"kind":"person","name":"Linney Yvonne","position":1,"cik":"0001810930","reported_name":"Linney Yvonne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T20:22:10.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000030","document":"wk-form4_1718914921.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810930/000141169024000030/wk-form4_1718914921.xml","form_type":"4"}},{"id":1473453,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":89731,"kind":"person","name":"Wong Vincent Jung-Fai","position":1,"cik":"0001898723","reported_name":"Wong Vincent Jung-Fai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T16:22:41.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000033","document":"wk-form4_1718914954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898723/000141169024000033/wk-form4_1718914954.xml","form_type":"4"}},{"id":1473312,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T16:22:31.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":30000,"derivative":{"exercise_price":0.7752,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001411690-24-000032","document":"wk-form4_1718914944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000141169024000032/wk-form4_1718914944.xml","form_type":"4"}},{"id":1489808,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:49:36.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":75000,"derivative":{"exercise_price":0.93,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-015624","document":"form4-06052024_090633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015624/form4-06052024_090633.xml","form_type":"4"}},{"id":1489807,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-06-05T21:49:36.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 54 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 9, 2023."}],"balance_after":64698,"source":{"system":"sec-edgar","filing":"0001415889-24-015624","document":"form4-06052024_090633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015624/form4-06052024_090633.xml","form_type":"4"}},{"id":1489806,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":90241,"kind":"person","name":"Kama Gulsen","position":1,"cik":"0001991106","reported_name":"Kama Gulsen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:48:08.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":75000,"derivative":{"exercise_price":0.93,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-015622","document":"form4-06052024_090604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015622/form4-06052024_090604.xml","form_type":"4"}},{"id":1489805,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":90241,"kind":"person","name":"Kama Gulsen","position":1,"cik":"0001991106","reported_name":"Kama Gulsen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T21:48:08.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001415889-24-015622","document":"form4-06052024_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015622/form4-06052024_090604.xml","form_type":"4"}},{"id":1489804,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:43:39.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":204000,"derivative":{"exercise_price":0.93,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001415889-24-015621","document":"form4-06052024_090635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015621/form4-06052024_090635.xml","form_type":"4"}},{"id":1489803,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-06-05T21:43:39.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 150 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 9, 2023."}],"balance_after":121813,"source":{"system":"sec-edgar","filing":"0001415889-24-015621","document":"form4-06052024_090635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015621/form4-06052024_090635.xml","form_type":"4"}},{"id":1489802,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:42:04.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":68000,"derivative":{"exercise_price":0.93,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001415889-24-015620","document":"form4-06052024_090600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015620/form4-06052024_090600.xml","form_type":"4"}},{"id":1489801,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2024-06-05T21:42:04.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date."}],"balance_after":18025,"source":{"system":"sec-edgar","filing":"0001415889-24-015620","document":"form4-06052024_090600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015620/form4-06052024_090600.xml","form_type":"4"}},{"id":1489800,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:40:14.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":75000,"derivative":{"exercise_price":0.93,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-015619","document":"form4-06052024_090611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015619/form4-06052024_090611.xml","form_type":"4"}},{"id":1489799,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-05T21:40:14.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 150 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 9, 2023 and 608 shares acquired under the ESPP from previous years."}],"balance_after":48245,"source":{"system":"sec-edgar","filing":"0001415889-24-015619","document":"form4-06052024_090611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924015619/form4-06052024_090611.xml","form_type":"4"}},{"id":1595278,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-05T22:48:35.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1081,"price":1.27,"value":1372.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 1,081 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 1,081 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 112,315 less shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023."}],"balance_after":31487,"source":{"system":"sec-edgar","filing":"0001415889-24-006811","document":"form4-03052024_100328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924006811/form4-03052024_100328.xml","form_type":"4"}},{"id":1595277,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-03-05T22:47:34.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1229,"price":1.27,"value":1560.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 1,229 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 1,229 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 268,058 less shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023."}],"balance_after":48644,"source":{"system":"sec-edgar","filing":"0001415889-24-006810","document":"form4-03052024_100327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924006810/form4-03052024_100327.xml","form_type":"4"}},{"id":1595276,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-05T22:46:30.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3073,"price":1.27,"value":3902.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 3,073 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 3,073 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 730,350 less shares of common stock (725,827 less shares held directly and 4,523 less shares held indirectly)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023."}],"balance_after":77663,"source":{"system":"sec-edgar","filing":"0001415889-24-006809","document":"form4-03052024_100317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924006809/form4-03052024_100317.xml","form_type":"4"}},{"id":1595275,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26206,"kind":"person","name":"Dixon Jonathan V.","position":1,"cik":"0001967837","reported_name":"Dixon Jonathan V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2024-03-05T22:44:40.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":402,"price":1.27,"value":510.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 402 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 402 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 35,343 less shares of common stock."}],"balance_after":3525,"source":{"system":"sec-edgar","filing":"0001415889-24-006808","document":"form4-03052024_100330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141588924006808/form4-03052024_100330.xml","form_type":"4"}},{"id":1776109,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-20T21:38:40.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of September 11, 2023 (the \"Vesting Commencement Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":40000,"derivative":{"exercise_price":3,"expiration_date":"2033-09-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-050186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123050186/doc4.xml","form_type":"4"}},{"id":1776108,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-09-20T21:38:40.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."}],"balance_after":317842,"source":{"system":"sec-edgar","filing":"0001209191-23-050186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123050186/doc4.xml","form_type":"4"}},{"id":1776107,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-20T21:26:47.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of September 11, 2023 (the \"Vesting Commencement Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":40000,"derivative":{"exercise_price":3,"expiration_date":"2033-09-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-050185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123050185/doc4.xml","form_type":"4"}},{"id":1776106,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-20T21:26:47.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."}],"balance_after":144794,"source":{"system":"sec-edgar","filing":"0001209191-23-050185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123050185/doc4.xml","form_type":"4"}},{"id":1776105,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":90241,"kind":"person","name":"Kama Gulsen","position":1,"cik":"0001991106","reported_name":"Kama Gulsen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-20T21:21:59.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":106000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest and become exercisable on September 11, 2024, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from September 11, 2024, subject to Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan, as amended) through each such applicable vesting date and the terms of the Company's 2020 Inducement Plan, as amended."}],"balance_after":106000,"derivative":{"exercise_price":3,"expiration_date":"2033-09-18","underlying":"Common Stock","underlying_shares":106000},"source":{"system":"sec-edgar","filing":"0001209191-23-050184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123050184/doc4.xml","form_type":"4"}},{"id":1851921,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47299,"kind":"person","name":"Rajkovic Aleksandar","position":1,"cik":"0001909592","reported_name":"Rajkovic Aleksandar","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:16:46.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000057","document":"wf-form4_168694659605901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000057/wf-form4_168694659605901.xml","form_type":"4"}},{"id":1851920,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":20815,"kind":"person","name":"Luderer Albert","position":1,"cik":"0001746822","reported_name":"Luderer Albert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:16:33.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000056","document":"wf-form4_168694656876329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000056/wf-form4_168694656876329.xml","form_type":"4"}},{"id":1852490,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47359,"kind":"person","name":"Linney Yvonne","position":1,"cik":"0001810930","reported_name":"Linney Yvonne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:16:03.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000055","document":"wf-form4_168694654303458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810930/000141169023000055/wf-form4_168694654303458.xml","form_type":"4"}},{"id":1851919,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41223,"kind":"person","name":"Vuori Kristiina MD","position":1,"cik":"0001612627","reported_name":"Vuori Kristiina MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:15:02.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000053","document":"wf-form4_168694648962541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000053/wf-form4_168694648962541.xml","form_type":"4"}},{"id":1851918,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":44686,"kind":"person","name":"TWOMEY CHRISTOPHER J","position":1,"cik":"0001238935","reported_name":"TWOMEY CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:14:46.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000052","document":"wf-form4_168694647426200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000052/wf-form4_168694647426200.xml","form_type":"4"}},{"id":1851917,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":47298,"kind":"person","name":"BARKER DAVID L","position":1,"cik":"0001189124","reported_name":"BARKER DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:14:30.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000051","document":"wf-form4_168694646055716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000051/wf-form4_168694646055716.xml","form_type":"4"}},{"id":1852489,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:17:02.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000058","document":"wf-form4_168694661088294.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000141169023000058/wf-form4_168694661088294.xml","form_type":"4"}},{"id":1852734,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":89731,"kind":"person","name":"Wong Vincent Jung-Fai","position":1,"cik":"0001898723","reported_name":"Wong Vincent Jung-Fai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:15:25.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan)."}],"balance_after":250000,"derivative":{"exercise_price":0.7458,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001411690-23-000054","document":"wf-form4_168694650593900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898723/000141169023000054/wf-form4_168694650593900.xml","form_type":"4"}},{"id":1856012,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":78564,"kind":"person","name":"Mamuszka Hannah","position":1,"cik":"0001810929","reported_name":"Mamuszka Hannah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-14T18:32:35.000Z","date":"2023-06-13","kind":"purchase","planned":false,"acquired":true,"shares":65789,"price":0.76,"value":49999.64,"ownership":{"direct":true},"balance_after":65789,"source":{"system":"sec-edgar","filing":"0001411690-23-000034","document":"wf-form4_168678194063640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810929/000141169023000034/wf-form4_168678194063640.xml","form_type":"4"}},{"id":1891349,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-16T22:23:46.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.6426,"value":9639.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.64160 to $0.643099, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":806474,"source":{"system":"sec-edgar","filing":"0001411690-23-000032","document":"wf-form4_168427581326105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000032/wf-form4_168427581326105.xml","form_type":"4"}},{"id":1891348,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":76581,"kind":"person","name":"Stewart Christopher P.","position":1,"cik":"0001822991","reported_name":"Stewart Christopher P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-16T22:22:21.000Z","date":"2023-05-12","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.6683,"value":33415.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6682 to $0.6683, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":281373,"source":{"system":"sec-edgar","filing":"0001411690-23-000031","document":"wf-form4_168427572747814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000031/wf-form4_168427572747814.xml","form_type":"4"}},{"id":1891346,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-05-16T22:20:04.000Z","date":"2023-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":41496,"price":0.66,"value":27387.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 41,496 shares of common stock that vested on May 12, 2023 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":297842,"source":{"system":"sec-edgar","filing":"0001411690-23-000030","document":"wf-form4_168427559071904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000030/wf-form4_168427559071904.xml","form_type":"4"}},{"id":1891347,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-16T22:18:28.000Z","date":"2023-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":50141,"price":0.66,"value":33093.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding by the Issuer of an aggregate of 50,141 shares of common stock that vested on May 12, 2023 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award."}],"balance_after":791474,"source":{"system":"sec-edgar","filing":"0001411690-23-000029","document":"wf-form4_168427549067289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000029/wf-form4_168427549067289.xml","form_type":"4"}},{"id":2007301,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-18T00:23:47.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":1400000,"derivative":{"exercise_price":1.63,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0001209191-23-010921","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010921/doc4.xml","form_type":"4"}},{"id":2007300,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":65880,"kind":"person","name":"Holmlin R. Erik","position":1,"cik":"0001579988","reported_name":"Holmlin R. Erik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-18T00:23:47.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,443 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 10, 2022 and 1,616 shares acquired under the ESPP on December 10, 2022."}],"balance_after":841615,"source":{"system":"sec-edgar","filing":"0001209191-23-010921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010921/doc4.xml","form_type":"4"}},{"id":2007299,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-18T00:22:56.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":560000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":560000,"derivative":{"exercise_price":1.63,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":560000},"source":{"system":"sec-edgar","filing":"0001209191-23-010920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010920/doc4.xml","form_type":"4"}},{"id":2007298,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":26209,"kind":"person","name":"OLDAKOWSKI MARK","position":1,"cik":"0001745566","reported_name":"OLDAKOWSKI MARK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-02-18T00:22:56.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,424 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 10, 2022 and 1,245 shares acquired under the ESPP on December 10, 2022."}],"balance_after":339338,"source":{"system":"sec-edgar","filing":"0001209191-23-010920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010920/doc4.xml","form_type":"4"}},{"id":2007297,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-18T00:21:53.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":560000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the \"Grant Date\") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date."}],"balance_after":560000,"derivative":{"exercise_price":1.63,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":560000},"source":{"system":"sec-edgar","filing":"0001209191-23-010919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010919/doc4.xml","form_type":"4"}},{"id":2007296,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":41704,"kind":"person","name":"Chaubey Alka","position":1,"cik":"0001821605","reported_name":"Chaubey Alka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-18T00:21:53.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,285 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the \"ESPP\") on June 10, 2022 and 2,509 shares acquired under the ESPP on December 10, 2022."}],"balance_after":124794,"source":{"system":"sec-edgar","filing":"0001209191-23-010919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919123010919/doc4.xml","form_type":"4"}}],"next_cursor":"2023-02-18T00:21:53.000000Z,2007296"}